NCT03338647 2021-12-02
SBRT or TACE for Advanced HCC
University of Aarhus
Phase 3 Unknown
Clinical Trials
12 trialsNCT04048317 2019-08-07
Effectiveness of Drug Eluting TACE in Primary HCC
Assiut University
Phase EARLY_PHASE1 Unknown
NCT03734068 2019-02-21
LIFDOX
International Group of Endovascular Oncology
Unknown
NCT01966133 2017-01-09
TACE as an Adjuvant Therapy After Hepatectomy for HCC
Fudan University
Phase 3 Unknown
NCT01272557 2014-04-01
SoraDox
Martin-Luther-Universität Halle-Wittenberg
Phase 2 Unknown
NCT00079027 2013-12-18
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00276705 2013-09-17
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01858207 2013-05-23
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
Chang Gung Memorial Hospital
Phase 2 Unknown
NCT01677468 2012-09-03
Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma
Hallym University Medical Center
Phase NA Unknown
NCT00471484 2011-06-22
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00990860 2011-01-05
START
Taipei Veterans General Hospital, Taiwan
Phase 2 Unknown
NCT01125020 2010-05-18
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
Shanghai Jiao Tong University School of Medicine
Phase NA Unknown